We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Real Hotel Grp | LSE:RHG | London | Ordinary Share | GB00B3D2NR11 | ORD 10P |
Bid Price | Offer Price | High Price | Low Price | Open Price | |
---|---|---|---|---|---|
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
- |
Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
---|---|---|---|---|
- | O | 0 | 1.875 | GBX |
Reed Health (RHG) Share Charts1 Year Reed Health Chart |
|
1 Month Reed Health Chart |
Intraday Reed Health Chart |
Date | Time | Title | Posts |
---|---|---|---|
21/1/2009 | 19:38 | Real Hotel Group | 6 |
20/8/2008 | 11:24 | Reed Health Group - takeout on the cards | 71 |
24/11/2005 | 20:24 | Reed Health with Charts | 7 |
07/9/2004 | 07:49 | reed health - profit warning again? | 1 |
07/6/2004 | 07:54 | Reed Health Group | 86 |
Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
---|
Top Posts |
---|
Posted at 25/11/2005 10:02 by schober have been trying to contact the non exec all week and failed miserably!!!had a conversation with a chap from investec who are advising the nonexec he assurmed me that they had done every thing possivle to get a higher price but he seeemed to be quite unaware of ahci!!!!!!!!!! hmmmmmmmmmmm! |
Posted at 24/11/2005 12:00 by schober A comparison!AHCI RHG Mcap £156m £19m TO £212m £90m Eps 2005 23.8p 2006 28p +17% at same mc/to ratio => rhg mcap of £66m or 200p a share but a lot of rhg is lower margin work |
Posted at 24/11/2005 11:58 by schober A comparison!AHCI RHG Mcap £156m £19m TO £212m £90m Eps2005 23.8p 2006 28p +17% at same mc/to ratio => rhg mcap of £66m or 200p a share but a lot of rhg is lower margin work |
Posted at 22/11/2005 09:24 by schober are there any other refusenicks out there; 16% havent caved in to reidys blandishments! will the independants pontificate?Response to Revised Offer by James Reed & Partners Plc 17 November 2005 The Independent Directors of Reed Health Group note the announcement by James Reed & Partners Plc that it will shortly increase its cash offer to 57.5 pence per share (the 'Increased Offer') to acquire all of the issued and to be issued share capital of Reed Health Group not already owned by James Reed & Partners Plc. The Independent Directors are considering the Offer and a further announcement will be made in due course. |
Posted at 07/9/2005 06:34 by amberspyglass the sad news is... their locum business is not doing so well... new contract reduced margins. they closed their leeds office - all staff there made redundant and now trained staff available to the many agencies in the ajoining area... what exactly do they have left? teachers gone for the price of a good car / locum doctors in decline / social workers - hot sector at the moment with every agency starting a social work branch.. they couldnt compete in teachers/ couldnt compete in doctors? why should they be able to compete in social workers? so this looks like a really good stock.... for shorting :-) (ps I've done it - but argue with the facts not the deramper) |
Posted at 05/7/2005 13:14 by schober "remove the use of non-framework approved agencies" i presume this means that alll that compliance work will now bear fruit and we will see an increase in turnover at reed doctors. Anyone know what our market share is in this area and how much goes to non-framework approved agencies? |
Posted at 22/3/2005 09:52 by schober looks like we'll have to trust trevor and angela to turn things round!Board changes 01/12/2004 Following a meeting of the Board held on 25 November 2004, Reed Health Group has announced that Trevor Goul-Wheeker has been appointed as Chief Executive Officer of the Company with effect from 7 December 2004. Trevor Goul-Wheeker is a highly experienced Chief Executive and is currently Executive Director at WHSmith. Previously, he was Non-Executive Chairman of Knowledge Support Systems plc, where he was instrumental in returning cash to shareholders, and Managing Director, Hammicks Bookshops Ltd, which was sold in 2003 following a major turnaround programme. His career also has encompassed a number of senior executive positions in Gestetner and Unilever, where Trevor ran both UK and International Divisions with significant sales into the health, education and institutional sectors. Reed Health Group has also announced that Angela Morris has been appointed as a Director of the Company at the Board meeting held today. Angela is currently Divisional Director, Reed Nurse and Social Care. She joined Reed Health Group in October 2002 as operations director of Reed Social Care, taking over the additional responsibility for Reed Nurse in April 2004. Angela Morris has worked in health and social care recruitment since 1988. She accepted her first Director’s appointment in 1997 for the social care and pharmacy divisions of CSG Healthcare where she stayed until 2000. During 2000, she completed a venture capital backed, £27m leveraged management buy-in acquiring two separate companies to form Corinth Healthcare, a healthcare recruitment company. ....not forgetting the new it system (it does sound quite good!) Reed Health Group Launches Interactive Financial Management Information System 10/02/2005 09:59:00 Reed Health Group, the provider of staffing services in the Health, Social Care and Education sectors in the UK, has today launched RHG Interactive ("RHGi"), a financial management information system, which is expected to revolutionise the way the Company works with its clients. This technology platform has been designed to provide Reed Health Group’s clients with the ability to maximise efficiency, reduce costs and streamline their staffing agency invoice processes. In response to clients concerns over costs, in terms of time and money, Reed Health Group conducted extensive research into the issues behind the management of high volumes of agency staffing invoices. Following an investment of £3 million, the Company has been able to create one of the most technically advanced financial management information systems in the market place............... |
Posted at 28/2/2005 09:07 by salpara111 I guess the only consistent thing about RHG is its ability to issue profits warnings.I had watched since the last bounce to 50 but was not convinced, then I was kicking myself that I hadnt got in when it reached 70 but now back where it started. I guess the bigger question is where will it go from here. I cant see people rushing back in again only to get stung again. |
Posted at 20/6/2004 11:28 by happyjoe Key contracts in this sector are up for renewal. Success will not affect share price (status quo), but opposite will lower it, so I would not expect any action by any potential bidder for 3-4 months. IMHO. |
Posted at 26/2/2004 21:44 by jpmorgan Have reviewed the interim results this evening. I have tried to group quantative/qualatatiSummary thoughts are below: (1)Reed Executive takes over RHG in next half year and takes advantage of scenario 2 buying an earning enhancing propostion. (2)The increase in senior management, integrated IT, and increased branches is laying foundation for a solid £6m profits profile (with associated cash flow) from July 04 onwards. Current market value is c£30m with no long term debt. Issues related to PASA etc should have been mitigated by this point. (3)A potential worst case scenario looking forward is that RHG is now in a commodity marketplace in 2 divisions. Thus RHG is currently unable to leverage profits effectively on large turnover due to intense competition and smarter working by the NHS. Thus profits will remain static under 5m for short to medium term. Cannot clearly get a view on whether scenario 2 or 3 or mix is likely. With real cash inflow continuing and markets growing I will wait till full year results before choosing to sell or remain long term holder. Any thoughts on RHG by BB? JPM |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions